NDC 16729-367-16 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-16
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Novadoz Pharmaceuticals LLC | c8197eea-e990-4c0e-bc2d-f080bac8de17 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | dcb39c6b-430d-4b3d-ba6f-5bf1efe116aa | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Smooth Even Glow | TINTED SUNSCREEN BROAD SPF30 | SKNVcare, LLC | 3fa48151-fcb9-3d35-e063-6394a90a2eb6 | 2025-09-25 | Warnings | 15FIX9V2JP |
| SUN BUFF SPF 30 MINERAL SUNSCREEN | ZINC OXIDE/TITANIUM DIOXIDE | SPF Ventures, LLC | 3f874062-ebab-8993-e063-6294a90abfc5 | 2025-09-24 | Warnings | 15FIX9V2JP |
| Benicar | OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | dc3f1fd4-5578-4c5d-be7b-12e3f8f3e7df | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Marlex Pharmaceuticals, Inc. | df881501-42ae-624a-e053-2995a90ab2a0 | 2025-09-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | bbf7e20d-dfc2-4115-8788-c0cac15a1148 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ERBORIAN CC RED CORRECT | ERBORIAN CC RED CORRECT SPF 25- OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE CREAM | Kolmask Co., Ld. | 09ca2d4b-e0c2-9961-e063-6394a90aa82e | 2025-09-18 | 15FIX9V2JP | |
| ELROEL Pang Pang Sun Cushion Plus | ZINC OXIDE, TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | MONOGLOT HOLDINGS Inc. | 5ffaad65-f0b2-416a-b0a3-b92e880641e4 | 2025-09-18 | Warnings | 15FIX9V2JP |
| CVS SPF 50 Face Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | CVS | 26a69a47-947a-a478-e063-6394a90aa468 | 2025-09-16 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ba2c08b-5ce5-4967-bc3b-2c73df9865af | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | ec6dce85-5c0b-475c-af0b-cbbc034f698f | 2025-09-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 60f3f17d-fd28-406d-97ca-9f01f5f1c72c | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | 24e308cc-7cec-4054-9627-66f743ed71b0 | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| sunscreen | TITANIUM DIOXIDE(NANO) | Mingyu (guangdong) Cosmetics Technology Co., Ltd | 3e6fe9f3-486b-bba7-e063-6294a90adf37 | 2025-09-10 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dbb07e2-971c-284d-e063-6294a90a437f | 2025-09-06 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6 | ENSULIZOLE,HOMOSALATE ,OCTINOXATE ,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3e069cb2-c4c5-abf5-e063-6394a90a56b0 | 2025-09-06 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NorthStar Rx LLC | 25318baf-9c2f-458f-b9ea-f52dabca49af | 2025-09-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 15FIX9V2JP 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 15FIX9V2JP 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.